Sequential re-rating: management describes the same offering landing bigger the second and third time around
The model's full reasoning — Q4 2023 call → NOWe need to determine if management conveys that successive engagements of the same kind are coming in at progressively larger size. Look for comparisons against own past, real and recurring, early stage. Scan transcript for mentions of deals, contracts, projects, customers, sites, programs. Look for phrases like "larger", "bigger", "broader", "longer", "more", "increasing size", "stepped up", "new customers starting at higher level", etc. Management discusses various segments. For example, in C&W Caribbean, they added subscribers, but that's volume. In Panama, B2B had strong year with high profile contract wins, but no mention of size escalation. In Liberty Networks, they mention new routes, but not necessarily larger deals. They mention "increased volume market share" and "value added services". No explicit comparison of deal size. In Puerto Rico, they talk about migration, not deals. In Costa Rica, they talk about subscriber adds. There is mention of "we are focusing on prepaid to postpaid migration" etc. No. The question asks specifically about successive engagements of same kind coming in at progressively larger size. I don't see any such statement. Management talks about growth in subscribers, revenue, but not about individual deal size increasing. They mention "high profile contract wins" but not that they are larger than before. They mention "new subsea route" but that's an investment, not a customer engagement. Thus answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| SGRY | Surgery Partners, Inc. | Q2 2022 | 2022-08-02 | B+ |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
AKYA · Q2 2023 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing a clear pattern of escalating project sizes in the translational/clinical space. Brian notes a migration from exploratory studies (reasonable size) to larger retrospective studies and even larger retrospective-prospective ongoing clinical studies, with projects moving "further and further downstream.
ASAN · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES Management describes exactly this pattern. Dustin notes the company is “closing larger deals and expanding seats across departments and geographies quickly in large organizations,” and that the growth in the >$50k cohort “reflected an acceleration in our largest enterprise customers.
SGRY · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing exactly this pattern for physician recruiting cohorts. Wayne notes that the 2022 cohorts are “no exception to this trend, bringing more cases with a higher overall net revenue per case than our 2021 cohorts did in the same period last year.